Loading
Latest filing published 12 Jan 2026 for Remus Pharmaceuticals Limited, €17k.
Only one filing by Alkaben Dipakkumar Shah is known so far (12 January 2026): an open-market purchase, €17k, in Remus Pharmaceuticals Limited. That is too little to draw conclusions. Every figure here comes from the filings published by SEBI (PIT + SAST) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
1 of 1 declaration